{{Rsnum
|rsid=10501920
|Gene=CNTN5
|Chromosome=11
|position=99622442
|Orientation=plus
|GMAF=0.1478
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=CNTN5
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 84.1 | 15.0 | 0.9
| HCB | 59.9 | 38.7 | 1.5
| JPT | 56.6 | 38.9 | 4.4
| YRI | 55.1 | 37.4 | 7.5
| ASW | 57.9 | 40.4 | 1.8
| CHB | 59.9 | 38.7 | 1.5
| CHD | 63.3 | 33.9 | 2.8
| GIH | 62.4 | 35.6 | 2.0
| LWK | 70.0 | 27.3 | 2.7
| MEX | 77.6 | 22.4 | 0.0
| MKK | 62.2 | 30.8 | 7.1
| TSI | 79.4 | 19.6 | 1.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs10501920
|PubMedID=17903304
|Condition=Atrial fibrillation
|Gene=CNTN5
|Risk Allele=
|pValue=9.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs10501920
|Name_s=
|Gene_s=CNTN5
|Feature=
|Evidence=PubMed ID:17903304; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes (Initial Sample Size: 1,341-1,345 individuals, depending on measure (Framingham); Replication Sample Size: NR). This variant is associated with Atrial fibrillation.
|Drugs=
|Drug Classes=
|Diseases=Atrial Fibrillation
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356430
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10501920
|overall_frequency_n=24
|overall_frequency_d=128
|overall_frequency=0.1875
|n_genomes=19
|n_genomes_annotated=0
|n_haplomes=22
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}